However, the ability of Cabozantinib to antagonize an increase in GM-CSF in 4T1 cells following irradiation indicates a utility in combination with radiotherapy, despite the lack of synergistic effects in terms of tumor growth or metastases control in our study. Here, CSF2 is linked to neoplasm.